Breaking Finance News

A statement released earlier today by Needham about Inogen (NASDAQ:INGN) bumps the target price to $108.00

Boasting a price of $91.11, Inogen (NASDAQ:INGN) traded -0.03% lower on the day. With the last stock price close up 3.36% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the date range. Inogen has recorded a 50-day average of $98.06 and a two hundred day average of $90.62. Volume of trade was down over the average, with 104,154 shares of INGN changing hands under the typical 178,860

Stating a potential upside of 0.19%, Needham upped the price target of Inogen (NASDAQ:INGN) to $108.00

On Monday May 15, 2017, Zacks Investment Research released a statement for Inogen (NASDAQ:INGN) bumped up the target price from $0.00 to $94.00 that suggested an upside of 0.15%.

Performance Chart


With a total market value of $0, Inogen has price-earnings ratio of 81.30 with a one year low of $50.24 and a one year high of $105.35 .

A total of 5 equity analysts have released a research note on INGN. zero equity analysts rating the company a strong buy, zero equity analysts rating the company a buy, zero equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $54.20.

Brief Synopsis About Inogen (NASDAQ:INGN)

Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.